Company / Capital Returned to Shareholders
IRONWOOD PHARMACEUTICALS INC Capital Returned to Shareholders History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$126.4M
FY2024
5-year range
$24.1M / $126.4M
FY2021-FY2024
Trend
-
vs FY2023
Sector context
#20 of 52
Health Care
What the data says
Capital Returned to Shareholders changed +424% YoY in FY2024, a notable deviation from the 2-year average annual change of +212%.
Based on SEC 10-K filings.
$126M in FY2024.
Improved from $24M to $126M over the past 3 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +73.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#20 of 52 in Health CareTop 38% of 52This company $126.4M Sector average $1.3B
▼
-90.5% below sector average
Key checks
Key Insights
- 3-year CAGR of +73.7%, indicating consistent growth.
- Ranks #20 out of 52 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $126.4M | - |
| FY2023 | - | - |
| FY2022 | $24.1M | +0.0% |
| FY2021 | $24.1M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026